NCBI Gene symbol: SLC22A18AS
lncRNA name in article Virus & Strain Name Dosage & Time point Cell line Experiment Type Fold change Expression P-value Differential expression quantification method Statistical method Year PubMed ID
SLC22A18AS Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) MOI = 2 ;
24 hr		 A-549 Human adenocarcinomic alveolar basal epithelial cells RNA-Seq 0.295194961 Downregulation 3.52E-20 student's t test  2020 32416070
SLC22A18AS Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) MOI = 2 ;
24 hr 		A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) RNA-Seq 0.380658243 Downregulation 1.69E-10 student's t test  2020 32416070
SLC22A18AS Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) MOI = 0.2 ;
24 hr		 A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) RNA-Seq 0.436780393 Downregulation 0 student's t test  2020 32416070
SLC22A18AS Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) MOI = 2 ;
24 hr		 Calu-3 Human adenocarcinomic lung epithelialcells RNA-Seq 0.332477819 Downregulation 0.001681595 student's t test  2020 32416070

* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose

.